NYSEArca - Delayed Quote USD

iShares iBoxx $ High Yield Corporate Bond ETF (HYG)

76.54 -0.17 (-0.22%)
At close: April 24 at 4:00 PM EDT
76.54 0.00 (0.00%)
After hours: April 24 at 7:31 PM EDT
Loading Chart for HYG
DELL
  • Previous Close 76.71
  • Open 76.67
  • Bid --
  • Ask --
  • Day's Range 76.37 - 76.70
  • 52 Week Range 71.68 - 78.08
  • Volume 37,496,575
  • Avg. Volume 38,951,366
  • Net Assets 16.92B
  • NAV 76.48
  • PE Ratio (TTM) 9.55
  • Yield 5.73%
  • YTD Daily Total Return 0.69%
  • Beta (5Y Monthly) 0.96
  • Expense Ratio (net) 0.49%

The underlying index is a rules-based index consisting of U.S. dollar-denominated, high yield corporate bonds for sale in the U.S. The fund will invest at least 80% of its assets in the component securities of the underlying index, and the fund will invest at least 90% of its assets in fixed income securities of the types included in the underlying index that the advisor believes will help the fund track the underlying index.

iShares

Fund Family

High Yield Bond

Fund Category

16.92B

Net Assets

2007-04-04

Inception Date

Performance Overview: HYG

Trailing returns as of 4/23/2024. Category is High Yield Bond.

YTD Return

HYG
0.69%
Category
1.67%
 

1-Year Return

HYG
8.58%
Category
10.40%
 

3-Year Return

HYG
0.84%
Category
2.07%
 

People Also Watch

Holdings: HYG

Sector Weightings

SectorHYG
Energy   100.00%
Real Estate   0.00%
Technology   0.00%
Utilities   0.00%
Industrials   0.00%
Healthcare   0.00%

Recent News: HYG

Research Reports: HYG

  • Analyst Report: Biogen Inc.

    Biogen and Idec merged in 2003, combining forces to market Biogen's multiple sclerosis drug Avonex and Idec's cancer drug Rituxan. Today, Rituxan and next-generation antibody Gazyva are marketed via a collaboration with Roche. Biogen also markets novel multiple sclerosis drugs Plegridy, Tysabri, Tecfidera, and Vumerity. In Japan, Biogen's MS portfolio is copromoted by Eisai. Hemophilia therapies Eloctate and Alprolix (partnered with Sobi) were spun off as part of Bioverativ in 2017. Biogen's newer products include Spinraza (SMA, with partner Ionis), Leqembi (Alzheimers, with partner Eisai), Skyclarys (Friedreich's Ataxia, Reata), Zurzuvae (post-partum depression, Sage), and Qalsody (ALS, Ionis). Biogen has several drug candidates in phase 3 trials in neurology-related fields.

    Rating
    Price Target
     
  • Analyst Report: Netflix, Inc.

    Netflix’s relatively simple business model involves only one business, its streaming service. It has the biggest television entertainment subscriber base in both the United States and the collective international market, with almost 250 million subscribers globally. Netflix has exposure to nearly the entire global population outside of China. The firm has traditionally avoided live programming or sports content, instead focusing on on-demand access to episodic television, movies, and documentaries. The firm recently began introducing ad-supported subscription plans, giving the firm exposure to the advertising market in addition to the subscription fees that have historically accounted for nearly all its revenue.

    Rating
    Price Target
     
  • Analyst Report: Meta Platforms, Inc.

    Meta is the world’s largest online social network, with nearly 4 billion family of apps monthly active users. Users engage with each other in different ways, exchanging messages and sharing news events, photos, and videos. The firm’s ecosystem consists mainly of the Facebook app, Instagram, Messenger, WhatsApp, and many features surrounding these products. Users can access Facebook on mobile devices and desktops. Advertising revenue represents more than 90% of the firm’s total revenue, with more than 45% coming from the U.S. and Canada and over 20% from Europe.

    Rating
    Price Target
     
  • Analyst Report: Amazon.com, Inc.

    Amazon is a leading online retailer and one of the highest-grossing e-commerce aggregators, with $386 billion in net sales and approximately $578 billion in estimated physical/digital online gross merchandise volume in 2021. Retail-related revenue represents approximately 80% of the total, followed by Amazon Web Services' cloud computing, storage, database, and other offerings (10%-15%), advertising services (5%), and other. International segments constitute 25%-30% of Amazon's non-AWS sales, led by Germany, the United Kingdom, and Japan.

    Rating
    Price Target
     

Related Tickers